BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6667711)

  • 1. RCS from human platelets: is it only thromboxane?
    Smith EF; Rücker W; Schrör K
    Eur J Pharmacol; 1983 Nov; 95(1-2):121-4. PubMed ID: 6667711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
    J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets.
    Lin CH; Kuo SC; Huang LJ; Huang TF; Teng CM
    Thromb Res; 1992 Apr; 66(1):61-73. PubMed ID: 1412184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the selective inhibition of platelet thromboxane synthesis on the platelet-subendothelium interaction.
    De La Cruz JP; Villalobos MA; Escalante R; Guerrero A; Arrebola MM; Sánchez de La Cuesta F
    Br J Pharmacol; 2002 Dec; 137(7):1082-8. PubMed ID: 12429581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of thromboxane and 12-HPETE formation by dazoxiben and its two thiophenic acid-substituted derivatives.
    Smith EF; Darius H; Ferber H; Schrör K
    Eur J Pharmacol; 1985 Jun; 112(2):161-9. PubMed ID: 3896821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet thromboxane production during endotoxin shock.
    Prancan A; Simon D; Pope L
    Agents Actions; 1981 Dec; 11(6-7):648-50. PubMed ID: 7340458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fish oil fatty acids and human platelets: dose-dependent decrease in dienoic and increase in trienoic thromboxane generation.
    Krämer HJ; Stevens J; Grimminger F; Seeger W
    Biochem Pharmacol; 1996 Oct; 52(8):1211-7. PubMed ID: 8937428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dominant role of thromboxane formation in secondary aggregation of platelets.
    Meyers KM; Seachord CL; Holmsen H; Smith JB; Prieur DJ
    Nature; 1979 Nov; 282(5736):331-3. PubMed ID: 503210
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of nicotine on the formation of prostacyclin-like activity and thromboxane in rabbit aorta and platelets.
    Alster P; Wennmalm A
    Br J Pharmacol; 1984 Jan; 81(1):55-60. PubMed ID: 6367870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of thromboxane A2 and aorta-contracting activity from platelets stimulated with modified C-reactive protein.
    Simpson RM; Prancan A; Izzi JM; Fiedel BA
    Immunology; 1982 Sep; 47(1):193-202. PubMed ID: 7118160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of coronary circulatory failure and thromboxane A2 release during coronary occlusion and reperfusion by 2-phenylaminoadenosine (CV-1808) in anesthetized dogs.
    Tanabe M; Terashita Z; Nishikawa K; Hirata M
    J Cardiovasc Pharmacol; 1984; 6(3):442-8. PubMed ID: 6202970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference of transmethylation inhibitors with thromboxane synthesis in rat platelets: evidence for the requirement of a methyl transfer reaction in platelet activation.
    Lecompte T; Randon J; Chignard M; Vargaftig BB; Dray F
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():441-7. PubMed ID: 6221560
    [No Abstract]   [Full Text] [Related]  

  • 13. Thromboxane-mediated activation of platelets and enhancement of platelet uptake onto collagen-coated glass or deendothelialized rabbit aorta. Comparative effects of a thromboxane antagonist (EPO45) and a thromboxane synthetase inhibitor (dazoxiben).
    Menys VC; Davies JA
    Lab Invest; 1984 Feb; 50(2):184-9. PubMed ID: 6546403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin and thromboxane synthesis by microsomes of rabbit ocular tissues.
    Kass MA; Holmberg NJ
    Invest Ophthalmol Vis Sci; 1979 Feb; 18(2):166-71. PubMed ID: 761971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory action of soluble elastin on thromboxane B2 formation in blood platelets.
    Sekiya K; Okuda H
    Biochim Biophys Acta; 1984 Mar; 797(3):348-53. PubMed ID: 6320905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased platelet thromboxane synthesis in diabetes mellitus.
    Halushka PV; Rogers RC; Loadholt CB; Colwell JA
    J Lab Clin Med; 1981 Jan; 97(1):87-96. PubMed ID: 7452084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin potentiates synthesis of thromboxane A2 in human platelets.
    Anderson WH; Mohammad SF; Chuang HY; Mason RG
    Adv Prostaglandin Thromboxane Res; 1980; 6():287-91. PubMed ID: 7386269
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of specific inhibitors of thromboxane A2 formation.
    Ladd N; Lewis GP
    Br J Pharmacol; 1980 May; 69(1):3-5. PubMed ID: 7378655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of aspirin and indomethacin on platelet and leukocyte thromboxane A2 formation.
    Maderna P; Colli S; Morazzoni G; Stragliotto E; Tremoli E
    Prostaglandins Leukot Med; 1985 Jun; 18(3):379-91. PubMed ID: 3927321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.
    Sinha AK; Rao AK; Willis J; Colman RW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6086-90. PubMed ID: 6577468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.